TGF-β induces TIAF1 self-aggregation via type II receptor-independent signaling that leads to generation of amyloid β plaques in Alzheimer's disease

The role of a small transforming growth factor beta (TGF-β)-induced TIAF1 (TGF-β1-induced antiapoptotic factor) in the pathogenesis of Alzheimer's disease (AD) was investigated. TIAF1 physically interacts with mothers against DPP homolog 4 (Smad4), and blocks SMAD-dependent promoter activation when overexpressed. Accordingly, knockdown of TIAF1 by small interfering RNA resulted in spontaneous accumulation of Smad proteins in the nucleus and activation of the promoter governed by the SMAD complex. TGF-β1 and environmental stress (e.g., alterations in pericellular environment) may induce TIAF1 self-aggregation in a type II TGF-β receptor-independent manner in cells, and Smad4 interrupts the aggregation. Aggregated TIAF1 induces apoptosis in a caspase-dependent manner. By filter retardation assay, TIAF1 aggregates were found in the hippocampi of nondemented humans and AD patients. Total TIAF1-positive samples containing amyloid β (Aβ) aggregates are 17 and 48%, respectively, in the nondemented and AD groups, suggesting that TIAF1 aggregation occurs preceding formation of Aβ. To test this hypothesis, in vitro analysis showed that TGF-β-regulated TIAF1 aggregation leads to dephosphorylation of amyloid precursor protein (APP) at Thr668, followed by degradation and generation of APP intracellular domain (AICD), Aβ and amyloid fibrils. Polymerized TIAF1 physically interacts with amyloid fibrils, which would favorably support plaque formation in vivo.

[1]  Y. Kirino,et al.  Phosphorylation-dependent Regulation of the Interaction of Amyloid Precursor Protein with Fe65 Affects the Production of β-Amyloid* , 2001, The Journal of Biological Chemistry.

[2]  M. Ball,et al.  Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*) , 1996, The Journal of Biological Chemistry.

[3]  W. Noble,et al.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.

[4]  L. Wakefield,et al.  Transforming Growth Factor-βs and Mammary Gland Involution; Functional Roles and Implications for Cancer Progression , 2009, Journal of Mammary Gland Biology and Neoplasia.

[5]  E. Mackenzie,et al.  Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription. , 2004, The Biochemical journal.

[6]  P. Greengard,et al.  Neuron‐Specific Phosphorylation of Alzheimer's β‐Amyloid Precursor Protein by Cyclin‐Dependent Kinase 5 , 2000, Journal of neurochemistry.

[7]  Yan Wang,et al.  Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice , 2009, The Journal of Neuroscience.

[8]  J. Heath,et al.  Transforming Growth Factor β1 Signaling via Interaction with Cell Surface Hyal-2 and Recruitment of WWOX/WOX1* , 2009, The Journal of Biological Chemistry.

[9]  B. Nannenga,et al.  Conformational Targeting of Fibrillar Polyglutamine Proteins in Live Cells Escalates Aggregation and Cytotoxicity , 2009, PloS one.

[10]  C. Klein,et al.  BclxL Changes Conformation upon Binding to Wild-type but Not Mutant p53 DNA Binding Domain* , 2009, The Journal of Biological Chemistry.

[11]  Tony Wyss-Coray,et al.  A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models. , 2006, Current Alzheimer research.

[12]  M. Probst-Kepper,et al.  Signatures of human regulatory T cells: an encounter with old friends and new players , 2006, Genome Biology.

[13]  L. Mucke,et al.  Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. , 2006, The Journal of clinical investigation.

[14]  M. Stefani,et al.  Protein Folding and Misfolding on Surfaces , 2008, International journal of molecular sciences.

[15]  Keizo Sugaya,et al.  Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases , 2009, Molecular Neurodegeneration.

[16]  K. Lau,et al.  Phosphorylation of thr668 in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress‐activated protein kinase 1b (Jun N‐terminal kinase‐3) , 2001 .

[17]  T. Blokzijl,et al.  High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells1 , 2002, Transplantation.

[18]  E. Mackenzie,et al.  Sp1 and Smad transcription factors co-operate to mediate TGF-β-dependent activation of amyloid-β precursor protein gene transcription , 2004 .

[19]  P. Courtoy,et al.  Phosphorylation of APP695 at Thr668 decreases gamma-cleavage and extracellular Abeta. , 2007, Biochemical and biophysical research communications.

[20]  R. Gebhardt,et al.  Inducible neuronal expression of transgenic TGF‐β1 in vivo: dissection of short‐term and long‐term effects , 2005, The European journal of neuroscience.

[21]  Gerard C Blobe,et al.  Roles for the type III TGF-beta receptor in human cancer. , 2010, Cellular signalling.

[22]  D. Selkoe,et al.  Physiological Regulation of the β-Amyloid Precursor Protein Signaling Domain by c-Jun N-Terminal Kinase JNK3 during Neuronal Differentiation , 2005, The Journal of Neuroscience.

[23]  Jun Tan,et al.  Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology , 2008, Nature Medicine.

[24]  Elizabeth Head,et al.  Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers , 2007, Molecular Neurodegeneration.

[25]  L. Hsu,et al.  Dramatic Co-Activation of WWOX/WOX1 with CREB and NF-κB in Delayed Loss of Small Dorsal Root Ganglion Neurons upon Sciatic Nerve Transection in Rats , 2009, PloS one.

[26]  Stefania Gimelli,et al.  Complex pathogenesis of Hirschsprung's disease in a patient with hydrocephalus, vesico-ureteral reflux and a balanced translocation t(3;17)(p12;q11) , 2009, European Journal of Human Genetics.

[27]  G. Glazner,et al.  TGF-β1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis , 2008, Neuroscience Letters.

[28]  N. Chang,et al.  TIAF1 Participates in the Transforming Growth Factor β1‐Mediated Growth Regulation , 2003, Annals of the New York Academy of Sciences.

[29]  Nan-Shan Chang,et al.  TIAF1 and p53 functionally interact in mediating apoptosis and silencing of TIAF1 abolishes nuclear translocation of serine 15-phosphorylated p53. , 2004, DNA and cell biology.

[30]  L. Schmued,et al.  Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons , 2005, Brain Research.

[31]  B. Liang,et al.  Transforming growth factor-β-induced transcription of the Alzheimer β-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads , 2002 .

[32]  Y.-D. Su,et al.  Surface plasmon-enhanced two-photon fluorescence microscopy for live cell membrane imaging , 2009, BiOS.

[33]  Galina Selivanova,et al.  Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound , 2002, Nature Medicine.

[34]  L. Launer,et al.  A TGF-β1 polymorphism association with dementia and neuropathologies: The HAAS , 2007, Neurobiology of Aging.

[35]  Y. Zhao,et al.  Cloning and characterization of a novel transforming growth factor-beta1-induced TIAF1 protein that inhibits tumor necrosis factor cytotoxicity. , 1998, Biochemical and biophysical research communications.

[36]  J. Heath,et al.  Hyaluronidase Induction of a WW Domain-containing Oxidoreductase That Enhances Tumor Necrosis Factor Cytotoxicity* , 2001, The Journal of Biological Chemistry.

[37]  B. Liang,et al.  Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads. , 2002, Biochemical and biophysical research communications.

[38]  L. Hsu,et al.  MPP+‐induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain‐containing oxidoreductase WOX1 , 2008, The European journal of neuroscience.

[39]  Q. Hong,et al.  Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-κB, JNK1, p53 and WOX1 during stress response , 2007, BMC Molecular Biology.

[40]  H. Lehrach,et al.  Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Shean-Jen Chen,et al.  Complement C1q Activates Tumor Suppressor WWOX to Induce Apoptosis in Prostate Cancer Cells , 2009, PloS one.